Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +69.87%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.42%
#5 Velvet Velvet +46.01%
#6 Cross Cross +36.90%
#7 Black Phoenix Black Phoenix +34.13%
#8 Cap Cap +19.51%
#9 DoubleZero DoubleZero +15.07%
#10 Humanity Humanity +11.75%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Fabino Enterprises Ltd Fabino Enterprises Ltd

Fabino Enterprises Ltd

FABINO
Rang in aandelen #39500
Operating from its Sonipat, India base since its incorporation in 2011, Fabino... Operating from its Sonipat, India base since its incorporation in 2011, Fabino Enterprises Limited is engaged in the manufacturing, marketing, trading, and packaging of pharmaceutical and wellness-oriented consumer products throughout India. Its extensive product portfolio, marketed under the Fabino and Keepshine brands, includes allopathic and select herbal medications—such as tablets, ointments, and syrups—along with various food and general wellness items. The company also extends its reach globally by exporting wellness and Fast-Moving Consumer Goods (FMCG) like coffee, malt powder, protein powder, and hair shampoo. Fabino's products are distributed and promoted via its own robust internal network and specialized sales force. Notably, the entity adopted its current name, Fabino Enterprises Limited, in June 2024, having previously been known as Fabino Life Sciences Limited.
Aandeelprijs
$0.22413867
Laatst gesynchroniseerd: 2026-05-25
Marktkapitalisatie
$463.14K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-24.40%
Land
IN
Handel Fabino Enterprises Ltd (FABINO)

Categorie

Healthcare
P/S-ratio voor Fabino Enterprises Ltd (FABINO)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Fabino Enterprises Ltd is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Fabino Enterprises Ltd van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.30 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.90 -
US